Remedent, Inc.
REMI
$0.05
$0.000.00%
| 03/31/2021 | 12/31/2020 | ||||
|---|---|---|---|---|---|
| Revenue | -264.15% | 4.85% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -264.15% | 4.85% | |||
| Cost of Revenue | -212.46% | 13.53% | |||
| Gross Profit | -295.98% | 0.05% | |||
| SG&A Expenses | -75.65% | 34.10% | |||
| Depreciation & Amortization | -28.74% | -2.25% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -245.99% | 23.98% | |||
| Operating Income | -670.83% | -76.51% | |||
| Income Before Tax | -201.29% | 4,481.82% | |||
| Income Tax Expenses | -187.50% | -- | |||
| Earnings from Continuing Operations | -201.63% | 4,372.73% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 317.95% | -316.67% | |||
| Net Income | -196.83% | 2,262.50% | |||
| EBIT | -670.83% | -76.51% | |||
| EBITDA | -417.32% | -67.09% | |||
| EPS Basic | 0.00% | 2,250.00% | |||
| Normalized Basic EPS | -- | 1,400.00% | |||
| EPS Diluted | 0.00% | 2,250.00% | |||
| Normalized Diluted EPS | -- | 1,400.00% | |||
| Average Basic Shares Outstanding | -- | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
